Visiopharm and Proscia have entered into a multi-year, strategic partnership to deliver deeply integrated AI-enabled solutions that drive breakthroughs in translational research and advance precision medicine. In addition to joint product integration, Visiopharm and Proscia have established a global reseller and support agreement to accelerate the delivery of these combined offerings to the market.
Featured Story:
Latest Articles
March 5, 2024
February 27, 2024